These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25446)

  • 21. [Clinical trial of oxyprothepin decanoate (author's transl)].
    Kabes J; Balon R; Hanzlícek L; Skovajsová M; Kozáková H
    Cesk Psychiatr; 1980 Feb; 76(1):16-25. PubMed ID: 6103755
    [No Abstract]   [Full Text] [Related]  

  • 22. Some studies in an institution for the mentally retarded.
    Sewell J; Werry JS
    N Z Med J; 1976 Oct; 84(574):317-9. PubMed ID: 14320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of anxiolytic property of 'CIBA-GO3315 A', a new butyrophenone.
    Mehta NC; Khorana AB
    J Assoc Physicians India; 1982 Jul; 30(7):433-6. PubMed ID: 6132911
    [No Abstract]   [Full Text] [Related]  

  • 24. Lithium and propranolol in aggression and self-injurious behavior in the mentally retarded.
    Luchins DJ; Dojka D
    Psychopharmacol Bull; 1989; 25(3):372-5. PubMed ID: 2626515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of the dexamethasone suppression test to detect depressive disorders of mentally retarded individuals.
    Pirodsky DM; Gibbs JW; Hesse RA; Hsieh MC; Krause RB; Rodriguez WH
    Am J Ment Defic; 1985 Nov; 90(3):245-52. PubMed ID: 4083305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ
    Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of lorazepam on hyperactivity in ratarded children.
    Walters A; Singh N; Beale IL
    N Z Med J; 1977 Nov; 86(600):473-5. PubMed ID: 24194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risperidone in the treatment of psychotic disorders associated with mental retardation].
    Franco MA; Herraiz M; Martínez MJ; Fernández MC; Conde V
    Actas Esp Psiquiatr; 2000; 28(4):251-6. PubMed ID: 11116796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Modification of self-injury and self-mutilation behavior--analysis of a single case intervention study of a boy in a school for mentally retarded].
    Lauth GW; Weiss SR
    Prax Kinderpsychol Kinderpsychiatr; 2003 Feb; 52(2):109-21. PubMed ID: 12647604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abuse-provoking characteristics of institutionalized mentally retarded individuals.
    Rusch RG; Hall JC; Griffin HC
    Am J Ment Defic; 1986 May; 90(6):618-24. PubMed ID: 3717218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of quetiapine on aggression and hostility in patients with schizophrenia.
    Arango C; Bernardo M
    Hum Psychopharmacol; 2005 Jun; 20(4):237-41. PubMed ID: 15830402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cisordinol and Buronil in the elderly. A controlled multi-center double-blind comparison].
    Nygaard HA; Bakke K; Brudvik E; Lien GK; Moe TJ; Elgen K
    Tidsskr Nor Laegeforen; 1987 Mar; 107(9):827-9. PubMed ID: 3296303
    [No Abstract]   [Full Text] [Related]  

  • 33. [Autoaggressive behavior of the mentally retarded--results of a survey].
    Wallner T
    Rehabilitation (Stuttg); 1984 Nov; 23(4):160-2. PubMed ID: 6515106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons.
    Ratey JJ; Sovner R; Mikkelsen E; Chmielinski HE
    J Clin Psychiatry; 1989 Oct; 50(10):382-4. PubMed ID: 2793836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A comparison of the antidepressive effects of danitracene and imipramine (author's transl)].
    Faltus F; Janecková E; Malá H
    Cesk Psychiatr; 1978 Apr; 74(2):61-6. PubMed ID: 357023
    [No Abstract]   [Full Text] [Related]  

  • 36. [Double blind study of the psychoanaleptic action of amineptic (1694) in mentally retarded children without personality disorders].
    Duché DJ
    Rev Neuropsychiatr Infant; 1976 Mar; 24(3):173-7. PubMed ID: 4879
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of naloxone and naltrexone on self-injury: a double-blind, placebo-controlled analysis.
    Barrett RP; Feinstein C; Hole WT
    Am J Ment Retard; 1989 May; 93(6):644-51. PubMed ID: 2655671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
    Vinci M
    Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707
    [No Abstract]   [Full Text] [Related]  

  • 39. Self-inflicted lesions of the mouth and lips in mentally retarded young subjects.
    Siragusa M; Ferri R; Russo R; Lentini M; Schepis C
    Eur J Dermatol; 2013; 23(6):843-8. PubMed ID: 24480580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic drug monitoring of zuclopenthixol in a double-blind placebo-controlled discontinuation study in adults with intellectual disabilities and aggressive behaviour.
    Schwarz V; Reis O; Glaser T; Thome J; Hiemke C; Haessler F
    Pharmacopsychiatry; 2014 Jan; 47(1):29-32. PubMed ID: 24307207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.